The Effects of Remimazolam Tosylate on Postoperative Memory Function in Young and Middle-Aged Patients Undergoing Laparoscopic Surgery

Purpose: This randomized controlled trial compared the effects of remimazolam tosylate versus propofol on postoperative memory function in young and middle-aged adults undergoing laparoscopic surgery. Patients and Methods: 228 patients were randomized to receive either remimazolam or propofol (n=114 each) for induction and maintenance of general anesthesia, guided by Bispectral Index (BIS). Memory and cognitive functions were assessed preoperatively and on postoperative days 1 and 3 using the Three-Word Recall Test (TRT), Memory and Executive Screening (MES), and Montreal Cognitive Assessment (MoCA), with a follow-up at one month via the Telephone Interview for Cognitive Status-modified (TICS-m). Serum levels of IL-6, S100β, and NfL were measured preoperatively, at 30 minutes, and 24 hours post-surgery. Perioperative parameters and adverse events were recorded. Results: The incidence of early postoperative memory decline on days 1 and 3 was significantly lower in the remimazolam group compared to the propofol group (P < 0.05). The remimazolam group also exhibited significantly lower postoperative levels of IL-6 and S100β, more stable hemodynamics, and a reduced incidence of hypotension and bradycardia (all P < 0.05). The incidence of postoperative cognitive dysfunction (POCD) did not differ significantly between groups. Multivariate analysis identified lower educational level, diabetes, propofol use, and longer anesthesia duration as independent risk factors for early postoperative memory decline. Conclusion: For young and middle-aged patients undergoing laparoscopic surgery, remimazolam reduces the incidence of early postoperative memory decline (within the first three days) and provides superior hemodynamic stability with a milder inflammatory response compared to propofol. However, no significant difference was observed in cognitive function at one month postoperatively, indicating that the benefits are primarily confined to the early recovery period. Keywords: remimazolam tosylate, propofol, postoperative memory function, laparoscopic surgery

Authors

Institutions

Publication Details

Journal
Drug Design Development and Therapy
Published
2026-03-01
DOI
https://doi.org/10.2147/dddt.s580654
Primary Topic
Intensive Care Unit Cognitive Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Effects of Remimazolam Tosylate on Postoperative Memory Function in Young and Middle-Aged Patients Undergoing Laparoscopic Surgery

Tianyue Yin, Ping Wu, Jingya Liu, Xinlu Yang et al.
Drug Design Development and Therapy
Intensive Care Unit Cognitive Disorders
article

The Effects of Remimazolam Tosylate on Postoperative Memory Function in Young and Middle-Aged Patients Undergoing Laparoscopic Surgery

Tianyue Yin, Ping Wu, Jingya Liu, Xinlu Yang, Keqiang He, Kai Zhao, Huimin Wang, Sheng Wang, Mengyu Li
article en

Abstract

Purpose: This randomized controlled trial compared the effects of remimazolam tosylate versus propofol on postoperative memory function in young and middle-aged adults undergoing laparoscopic surgery. Patients and Methods: 228 patients were randomized to receive either remimazolam or propofol (n=114 each) for induction and maintenance of general anesthesia, guided by Bispectral Index (BIS). Memory and cognitive functions were assessed preoperatively and on postoperative days 1 and 3 using the Three-Word Recall Test (TRT), Memory and Executive Screening (MES), and Montreal Cognitive Assessment (MoCA), with a follow-up at one month via the Telephone Interview for Cognitive Status-modified (TICS-m). Serum levels of IL-6, S100β, and NfL were measured preoperatively, at 30 minutes, and 24 hours post-surgery. Perioperative parameters and adverse events were recorded. Results: The incidence of early postoperative memory decline on days 1 and 3 was significantly lower in the remimazolam group compared to the propofol group (P < 0.05). The remimazolam group also exhibited significantly lower postoperative levels of IL-6 and S100β, more stable hemodynamics, and a reduced incidence of hypotension and bradycardia (all P < 0.05). The incidence of postoperative cognitive dysfunction (POCD) did not differ significantly between groups. Multivariate analysis identified lower educational level, diabetes, propofol use, and longer anesthesia duration as independent risk factors for early postoperative memory decline. Conclusion: For young and middle-aged patients undergoing laparoscopic surgery, remimazolam reduces the incidence of early postoperative memory decline (within the first three days) and provides superior hemodynamic stability with a milder inflammatory response compared to propofol. However, no significant difference was observed in cognitive function at one month postoperatively, indicating that the benefits are primarily confined to the early recovery period. Keywords: remimazolam tosylate, propofol, postoperative memory function, laparoscopic surgery

Drug Design Development and TherapyVol. Volume 20
Wannan Medical College (CN), University of Science and Technology of China (CN), Anhui Provincial Hospital (CN)
Quality Education
Openalex Percentile: Top 4%
Intensive Care Unit Cognitive Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.